Andrew Littlehale

Chief Financial Officer, Macrolide Pharmaceuticals

G2: Early Stage Pharma/Biotech Licensing

America's Cup A/B

This workshop will focus on approaches and best practices when structuring early stage pharmaceutical and biotech IP deals in order to maximize value to both sides, including building in options and milestones, as well as considering the tax and financial reporting implications of legal entity structure.